Previous studies have demonstrated the Paclitaxel-mediated induction of PD-L1 expression in ovarian and other solid tumor types [19,49], as well as a potential correlation between Sp17 expression and chemoresistance in clear cell ovarian carcinoma [12]. This evidence concerns the gene CD274 and ovarian clear cell cancer.